MDRX - Allscripts Healthcare Solutions, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
10.06
+0.04 (+0.40%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close10.02
Open10.07
Bid10.02 x 4000
Ask10.10 x 3200
Day's Range10.01 - 10.10
52 Week Range8.54 - 12.40
Volume2057416
Avg. Volume1,745,787
Market Cap1.6B
Beta (3Y Monthly)1.42
PE Ratio (TTM)8.04
EPS (TTM)1.25
Earnings DateFeb 19, 2020 - Feb 24, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date2008-10-07
1y Target Est12.26
  • Business Wire

    Allscripts Announces Pricing of $200 Million Convertible Senior Notes Offering

    Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) ("Allscripts") today announced the pricing of its previously disclosed private offering of $200 million aggregate principal amount of its 0.875% convertible senior notes due 2027 (the "notes"). Allscripts has also granted the initial purchasers of the notes an option to purchase, within a 13-day period beginning on, and including, the date on which the notes are first issued, up to an additional $30 million aggregate principal amount of the notes. The notes are being offered only to qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The offering and sale of the notes to the initial purchasers is expected to close on December 9, 2019, subject to customary closing conditions.

  • Why Is AllScripts (MDRX) Down 7% Since Last Earnings Report?
    Zacks

    Why Is AllScripts (MDRX) Down 7% Since Last Earnings Report?

    AllScripts (MDRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Business Wire

    Allscripts Announces $200 Million Convertible Senior Notes Offering

    Allscripts also expects to grant the initial purchasers of the notes an option to purchase, within a 13-day period beginning on, and including, the date on which the notes are first issued, up to an additional $30 million aggregate principal amount of the notes. The notes will be senior, unsecured obligations of Allscripts, and interest on the notes will be payable semiannually in arrears. Conversions of the notes may be settled in cash, shares of Allscripts’ common stock, or a combination of cash and shares of Allscripts’ common stock, at Allscripts’ election.

  • Business Wire

    EPSi Announces Release of Advanced Analytics Offering

    EPSi, Allscripts’ (MDRX) flagship budgeting, planning/forecasting, cost accounting and financial decision support platform, announced a new advanced analytics product and services solution to the marketplace. The Advanced Analytics platform provides “out of the box” business intelligence data visualizations that will enable hospital decision makers to analyze current performance, utilizing EPSi’s flexible data model to incorporate a wide range of clinical, financial and operational data. “As EPSi has continued to innovate on our flexible platform, we saw the need to offer new business intelligence capabilities to enable our clients to leverage the rich data in our fully integrated database, which can be further enriched through the use of our Data Extender tool to add even more data to patient records, service lines and more,” said Ralph Keiser, CEO of EPSi.

  • MDRX or CERN: Which Is the Better Value Stock Right Now?
    Zacks

    MDRX or CERN: Which Is the Better Value Stock Right Now?

    MDRX vs. CERN: Which Stock Is the Better Value Option?

  • One Thing To Remember About The Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Share Price
    Simply Wall St.

    One Thing To Remember About The Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Share Price

    Anyone researching Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) might want to consider the historical...

  • Is AllScripts Healthcare (MDRX) Stock Undervalued Right Now?
    Zacks

    Is AllScripts Healthcare (MDRX) Stock Undervalued Right Now?

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

  • San Gorgonio Hospital Picks Allscripts Sunrise Community Care
    Zacks

    San Gorgonio Hospital Picks Allscripts Sunrise Community Care

    Allscripts' (MDRX) Sunrise Community Care is an Azure-hosted platform offering clinical, financial and ambulatory content.

  • Business Wire

    San Gorgonio Memorial Hospital selects Allscripts electronic health record suite for community hospitals

    Allscripts Healthcare Solutions today announced that San Gorgonio Memorial Hospital selected its electronic health record suite SunriseTM Community Care, which is built specifically for community hospitals.

  • Pulse8 Presenting as a Panelist on Provider-Health Plan Relationships During the RISE Risk Adjustment Forum in Scottsdale, AZ
    Business Wire

    Pulse8 Presenting as a Panelist on Provider-Health Plan Relationships During the RISE Risk Adjustment Forum in Scottsdale, AZ

    In its 14th year, the annual RISE Risk Adjustment Forum acts as a resource for health professionals seeking expert knowledge and continuous improvements to risk adjustment programs from experienced industry specialists, including Pulse8, which is part of Veradigm™, an Allscripts (MDRX) business unit. This year’s forum will include Pulse8’s Caralyn Maerz, Director of Provider Engagement, as a panelist to discuss leveling up your provider-health plan relationships on Wednesday, November 13th, from 11:30am - 12:30pm MST at the Fairmont Scottsdale Princess in Scottsdale, Arizona. “I am privileged to be speaking on a panel alongside industry leaders spanning from risk-adjustment experts to provider educators and even medical professors,” stated Caralyn Maerz, Pulse8’s Director of Provider Engagement.

  • MDRX or TRHC: Which Is the Better Value Stock Right Now?
    Zacks

    MDRX or TRHC: Which Is the Better Value Stock Right Now?

    MDRX vs. TRHC: Which Stock Is the Better Value Option?

  • Thomson Reuters StreetEvents

    Edited Transcript of MDRX earnings conference call or presentation 4-Nov-19 9:30pm GMT

    Q3 2019 Allscripts Healthcare Solutions Inc Earnings Call

  • Allscripts (MDRX) Q3 Earnings Beat Estimates, Improve Y/Y
    Zacks

    Allscripts (MDRX) Q3 Earnings Beat Estimates, Improve Y/Y

    Allscripts (MDRX) third-quarter results gain from growth in bookings and solid segmental performance. Contraction in both gross and operating margins remains a woe.

  • AllScripts Healthcare (MDRX) Beats Q3 Earnings Estimates
    Zacks

    AllScripts Healthcare (MDRX) Beats Q3 Earnings Estimates

    AllScripts (MDRX) delivered earnings and revenue surprises of 6.25% and -1.20%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

  • Business Wire

    Allscripts Announces Third Quarter 2019 Results

    CHICAGO-- -- Strong third quarter bookings of $236 million, up 19% year-over-year GAAP EPS ; 6% year-over-year growth in non-GAAP diluted EPS to $0.17 Extended Allscripts Sunrise platform with Northwell Health through 2027 Repurchased $46 million of stock in the third quarter Allscripts Healthcare Solutions, Inc. announced its financial results for the three and nine months ended September 30, 2019. ...

  • This Hedge Fund Can Still Deliver Double Digit Returns: Here Are Its Top Picks
    Insider Monkey

    This Hedge Fund Can Still Deliver Double Digit Returns: Here Are Its Top Picks

    Tamarack Capital Management was founded by Justin John Ferayorni, who remained the fund’s Chief Investment Officer and Portfolio Manager. Mr. Ferayorni holds A.B. degree in Chemistry from Princeton University, as well as Chartered Financial Analyst designation. Prior to founding Tamarack Capital Management, he worked as Healthcare Analyst and Portfolio Manager. He also held a position of […]

  • AllScripts Healthcare (MDRX) Expected to Beat Earnings Estimates: Should You Buy?
    Zacks

    AllScripts Healthcare (MDRX) Expected to Beat Earnings Estimates: Should You Buy?

    AllScripts (MDRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Why AllScripts (MDRX) Could Beat Earnings Estimates Again
    Zacks

    Why AllScripts (MDRX) Could Beat Earnings Estimates Again

    AllScripts (MDRX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

  • Business Wire

    Allscripts to release third-quarter 2019 financial results November 4

    Allscripts management plans to host a conference call and webcast to discuss the company's earnings and other information at 4:30 p.m. Eastern Time that same day. The Allscripts earnings announcement will be distributed immediately after the close of regular stock market hours on November 4, 2019. The announcement will also be available at Allscripts investor relations website.

  • Volatility 101: Should Allscripts Healthcare Solutions (NASDAQ:MDRX) Shares Have Dropped 19%?
    Simply Wall St.

    Volatility 101: Should Allscripts Healthcare Solutions (NASDAQ:MDRX) Shares Have Dropped 19%?

    In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...

  • Here's Why You Should Add Allscripts to Your Portfolio Now
    Zacks

    Here's Why You Should Add Allscripts to Your Portfolio Now

    Allscripts' (MDRX) focus on innovation makes it a worthy investment pick.

  • Business Wire

    Northwell Health extends partnership with comprehensive Allscripts Sunrise™ platform through 2027

    Allscripts Healthcare Solutions (MDRX) today announced that Northwell Health has extended its engagement with the comprehensive Allscripts Sunrise inpatient platform through December 2027. Sunrise is currently in use at 19 Northwell hospitals. Northwell Health—New York State’s largest health system, which has been live on Sunrise since 2005—continues to expand the platform’s use as additional Northwell Health facilities come on board.

  • Veradigm Health joins Harvard Pilgrim to develop next phase of FDA’s Sentinel System
    Business Wire

    Veradigm Health joins Harvard Pilgrim to develop next phase of FDA’s Sentinel System

    Veradigm™, an Allscripts (MDRX) business unit dedicated to simplifying healthcare with data-driven health insights and technologies to help manage cost and improve health outcomes, announced today that its Life Sciences business unit joins the Harvard Pilgrim Healthcare Institute and other collaborating partners to continue to develop the FDA Sentinel System, the largest multisite distributed database in the world dedicated to drug safety.

  • MDRX vs. HMSY: Which Stock Is the Better Value Option?
    Zacks

    MDRX vs. HMSY: Which Stock Is the Better Value Option?

    MDRX vs. HMSY: Which Stock Is the Better Value Option?

  • Veeva Systems to Improve Patient Outcome With Crossix Buyout
    Zacks

    Veeva Systems to Improve Patient Outcome With Crossix Buyout

    The latest acquisition fortifies Veeva Systems' (VEEV) foothold in the HCIT space further.